Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PCR testing for TB could lead to significant hospital savings -- AACC outcomes study.

This article was originally published in The Gray Sheet

Executive Summary

PCR TESTING FOR TUBERCULOSIS: "HUGE" COST SAVINGS could be achieved through TB-negative patients sent home early because of faster diagnosis via polymerase chain reaction, according to preliminary data from an American Association for Clinical Chemistry outcomes study. The preliminary findings, which were based on an economic analysis of 54 patients tested for TB, were presented at the annual meeting of the AACC in Anaheim, California on July 17 by Karen Kaul, MD, PhD, Evanston Hospital, Evanston, Illinois.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT004508

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel